Thrive Wealth Management, LLC

SEC CIK: 0001847610
Latest filing: Jul 7, 2026

SEC filings (opens in a new tab)

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by Thrive Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overview All 13F holders of TERN Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2025

Holdings of TERN by Thrive Wealth Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−10,500−100.0%	Sold out	Holders
Q1 2025	10,500	$29.0K	<0.1%	+10,500	New	Holders